tiprankstipranks
Revance Therapeutics (RVNC)
NASDAQ:RVNC

Revance Therapeutics (RVNC) Ownership - Who Owns Revance Therapeutics?

555 Followers

Revance Therapeutics (RVNC) Ownership Overview

12.84%33.94%48.57%4.65%
12.84% Insiders
48.57% Other Institutional Investors
4.65% Public Companies and
Individual Investors
The ownership structure of Revance Therapeutics (RVNC) stock is a mix of institutional, retail and individual investors. Approximately 82.50% of the company’s stock is owned by Institutional Investors, 12.84% is owned by Insiders and 4.65% is owned by Public Companies and Individual Investors.
The ownership structure of Revance Therapeutics (RVNC) stock is a mix of institutional, retail and individual investors. Approximately 82.50% of the company’s stock is owned by Institutional Investors, 12.84% is owned by Insiders and 4.65% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 17, 2024
Erica Jordan
Chief Commercial Officer
Sold$9090
Mar 19, 2024Sold$67436
Mar 19, 2024
Dwight Moxie
Clo & Gc
Sold$58276
Mar 19, 2024Sold$62149

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Bought$97937
Mar 31, 2024Bought$1230000
Mar 31, 2024Bought$2952000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,730,357Institution6.44%21,267,928
5,202,716Institution4.98%16,440,583
5,026,711Institution4.81%15,884,407
4,097,249Institution3.92%12,947,307
4,070,716Institution3.90%12,863,463
3,096,650Insider2.96%9,785,414
3,096,650Insider2.96%9,785,414
3,096,650Insider2.96%9,785,414
2,480,152Institution2.37%7,837,280
1,845,529Institution1.77%5,831,872

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,730,357Institution6.44%21,267,928
5,026,711Institution4.81%15,884,407
4,070,716Institution3.90%12,863,463
2,480,152Institution2.37%7,837,280
1,845,529Institution1.77%5,831,872
1,623,916Institution1.55%5,131,575
953,114Institution0.91%3,011,840
937,554Institution0.90%2,962,671
936,581Institution0.90%2,959,596
905,194Institution0.87%2,860,413

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,094,072Institution2.96%11,169,600
2,078,455Institution1.99%6,567,918
1,363,106Institution1.31%4,920,813
738,049Institution0.71%2,332,235
674,411Institution0.65%2,131,139
421,738Institution0.40%1,273,649
335,053Institution0.32%1,209,541
326,254Institution0.31%1,177,777
318,964Institution0.31%963,271
29,764Institution0.03%864,942

FAQ

Who Owns Revance Therapeutics (RVNC)?
According to the latest TipRanks data, approximately 48.57% of the company's stock is held by institutional investors, 12.84% is held by insiders, and 4.65% is held by retail investors.
    What percentage of Revance Therapeutics (RVNC) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 48.57% of Revance Therapeutics (RVNC) stock is held by institutional investors.
      What percentage of Revance Therapeutics (RVNC) stock is held by retail investors?
      According to the latest TipRanks data, approximately 4.65% of Revance Therapeutics (RVNC) stock is held by retail investors.
        Who owns the most shares of Revance Therapeutics (RVNC)?
        SMALLCAP World Fund Inc owns the most shares of Revance Therapeutics (RVNC).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis